Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab

Migraine is a highly disabling neurological condition, and preventative treatment still remains problematic, due to aspecificity of the majority of the currently available prophylactic drugs. Calcitonin-gene-related peptide (CGRP) plays a crucial role in migraine pathophysiology; agents aimed at blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Giamberardino, Maria Adele, Affaitati, Giannapia, Costantini, Raffaele, Cipollone, Francesco, Martelletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727105/
https://www.ncbi.nlm.nih.gov/pubmed/29263689
http://dx.doi.org/10.2147/JPR.S128143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727105/
https://www.ncbi.nlm.nih.gov/pubmed/29263689
http://dx.doi.org/10.2147/JPR.S128143

Ejemplares similares